Blockade of voltage-gated sodium (Na+) channels by local anesthetics represents the main mechanism for inhibition of impulse propagation. Local anesthetic induced potassium (K+) channel inhibition is also known to influence transmission of sensory impulses and to potentiate inhibition. K+ channels involved in this mechanism may belong to the emerging family of background tandem pore domain K+ channels (2P K+ channels). To determine more precisely the effects of local anesthetics on members of this ion channel family we heterologously expressed the 2P K+ channels TASK-2 (KCNK5), TASK-1 (KCNK3) and chimeric TASK-1/TASK-2 channels in oocytes of Xenopus laevis. TASK-2 cDNAtransfected HEK 293 cells were used for single channel recordings. Local anesthetic inhibition of TASK-2 was dose-dependent, agent-specific, and stereoselective. The IC 50 s' for R(+)-bupivacaine and S(-)-bupivacaine were 17 and 43 µM and for R(+)-ropivacaine and S(-)-ropivacaine 85 and 236 µM. Lidocaine 1 mM inhibited TASK-2 currents by 55 ± 4%, while its quaternary positively charged analogue N-ethyl lidocaine (QX314) had no effect. 100 µM bupivacaine decreased channel open probability from 20.8 ± 1.6% to 5.6 ± 2.2%.
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The molecular mechanisms of local anesthetic inhibition of voltage-gated sodium (Na+) channels and the resulting blockade of propagation of compound action potentials are welldescribed (Ragsdale et al., 1994) . In addition to the recognized importance of Na+ channel inhibition for peripheral and neuroaxial nerve block, other ion channels also contribute to local anesthetic action (Butterworth and Strichartz, 1990) . Blockade of potassium (K+) channels has been shown to potentiate local anesthetic-induced impulse inhibition (Drachman and Strichartz, 1991) . Local anesthetics inhibit a number of heterologously expressed voltage-gated K+ channels including hKv1.5, Kv2.1, Kv4.3, KvLQT1 and G protein-coupled inward rectifying K+ channels (GIRK) at micromolar concentrations (Zhou et al., 2001; González et al., 2001b) . In addition, local anesthetics inhibit K+ currents in various neuronal preparations, including transient K+ currents in rat dorsal horn neurones (Olschewski et al., 1998) and sustained K+ currents in isolated rat dorsal root ganglion neurones (Komai and McDowell, 2001 ) and amphibian sciatic nerves (Bräu et al., 1998) .
Local anesthetics are also potent inhibitors of the newly discovered third superfamily of K+ channels, i.e. the tandem pore domain K+ channels (2P K+ channels) (Kindler et al., 1999) . The 2P K+ channels are named KCNK channels according to the HUGO Gene Nomenclature Committee (http://www.gene.ucl.ac.uk/nomenclature/genefamily/KCN.shtml).
The structural orientation of these K+ channel subunits probably consists of four transmembrane segments and two pore-forming domains in tandem within their primary amino acid sequence with amino-and carboxy (C)-terminals arrayed intracellularly (for review see Goldstein et al., 2001 ). Most of these 2P K+ channels are widely expressed in the central nervous system (CNS) (Talley et al., 2001) , and their physiological role and function is emerging. They are believed to constitute the molecular entities of background or leak K+ conductances involved in the control of the resting membrane potential and firing pattern of This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on March 26, 2003 as DOI: 10.1124 at ASPET Journals on November 4, 2016 jpet.aspetjournals.org Downloaded from excitable cells; inhibition of these channels produces membrane depolarization (Eglen et al., 1999; Kindler et al., 1999) . Thus, local anesthetics could potentiate impulse inhibition by blockade of these 2P K+ channels. Local anesthetic-induced depolarization of the resting membrane potential of cells expressing these channels would promote formation of the open and inactivated states of voltage-gated Na+ channels, thereby increasing the affinity of Na+ channels for local anesthetics.
Moreover, inhibition of 2P K+ channels also increases membrane excitability and may therefore contribute to the cardiotoxic and excitotoxic side effects of local anesthetics.
The background K+ conductances in cardiomyocytes (Aimond et al., 2000; Terrenoire et al., 2001 ) and cerebellar granule and Purkinje neurones (Millar et al., 2000; Bushell et al., 2002) are carried, at least in part, by 2P K+ channels. Bupivacaine, which is the most toxic local anesthetic clinically used, inhibits the background 2P K+ channels TASK-1 and TREK-1 (Kindler et al., 1999) , both expressed in heart and CNS, at concentrations achieved with inadvertent intravascular injection (~ 20 µM) (Kotelko et al., 1984) . Recently, it has been shown that blockade of TASK-1 currents is responsible for the arrhythmogenic effects of platelet-activating factor in murine ventricular myocytes (Barbuti et al., 2002) . In the present study we examined the local anesthetic inhibition of the 2P K+ channel TASK-2, which is expressed in heart and CNS (Gray et al., 2000; Gabriel et al., 2002) , with special attention to both stereoselectivity and structure-activity relations. The typical local anesthetic molecule is a tertiary amine attached to a substituted aromatic ring by an intermediate chain containing either an ester or amide linkage; local anesthetics are therefore classified as aminoester or aminoamide compounds. It has been shown that aminoester local anesthetics are more potent inhibitors of resting Na+ channels JPET #49809
Materials and Methods
Two electrode voltage-clamp electrophysiological recording and analysis. The present study was approved by the Committee on Animal Research of the University of California, San Francisco. The methods of oocyte harvesting and injection of complementary ribonucleic acid (cRNA) were performed as previously described (Kindler et al., 1999) .
Lidocaine, racemic bupivacaine, tetracaine, benzocaine and N-ethyl lidocaine (QX314) were purchased from Sigma ® (St. Louis, MO). R(+)-and S(-)-bupivacaine and R(+)-, S(-)-, and racemic ropivacaine were kindly provided by AstraZeneca Pharmaceuticals (Södertälje, Sweden). Stock solutions of local anesthetics were prepared in frog Ringer's solution (FR) (in mM: 115 NaCl, 2.5 KCl, 1.8 CaCl 2 , 10 HEPES, pH 7.6) and kept at 4°C
for no more than 4 weeks. A stock solution of 1 M benzocaine in ethanol and 1 mM QX314 in FR were made up immediately before the experiments.
Oocytes were studied by two microelectrode voltage-clamp and current-clamp techniques using a GeneClamp 500B amplifier (Axon Instruments, Foster City, CA). For the voltage-clamp experiments, the holding potential was -80 mV. Voltage pulse protocols used 1-s steps ranging from -140 to +40 mV in 20-mV increments, with 1.5-s interpulse intervals.
Electrophysiological studies were performed at room temperature (20-23°C) in a 25-µl recording chamber perfused with FR at a rate of approximately 4-5 ml/min. Local anesthetic solutions were applied for 2-4 min prior to voltage pulse protocols, and washout experiments were performed after 2-4 min superfusion with local anesthetic-free FR solution. 
where f = fractional block at each voltage, Em = membrane potential, z = valence, δ = Woodhull coefficient (fraction of the electric field that the blocker experiences), and F, R and T have their usual meanings in thermodynamics. For calculations of the Woodhull coefficient δ, the effective charge z was assumed to be +1.
The time constant (τ) for TASK-2 activation was estimated by fitting it to the following one phase exponential equation (Prism, GraphPad Software, Inc., San Diego, CA): Activation kinetics. Under control conditions, TASK-2 currents display a time-dependent activation (time constant τ = 147 ± 5 ms, measured at +40 mV, n=5, and τ = 120 ± 9 ms, measured at -20 mV, n=7) and are non-inactivating over the entire pulse period (1 s), as previously described (Reyes et al., 1998; Gray et al., 2000) . The time constant of the activation process was significantly lower at higher drug concentrations (τ = 96 ± 8 ms for 100 µM S(-)-bupivacaine, n=5, vs. 134 ± 14 ms for 3 µM S(-)-bupivacaine, n=5, measured at +40 mV; p < 0.05). However, the effect of bupivacaine on the activation time constant
was not stereoselective (τ = 113 ± 6 ms for 10 µM S(-)-bupivacaine, n=4, vs. 109 ± 6 ms for 10 µM R(+)-bupivacaine, n=4, measured at +40 mV; p > 0.05).
Single channel openings. Cell attached patches from cells transfected with an expression plasmid coding for TASK-2 showed non-inactivating baseline channels that conducted outward currents at depolarized potentials and inward currents at hyperpolarized potentials (Fig. 4A ). This pattern of channel activity was not observed in sham transfected or untransfected cells. The application of racemic bupivacaine (100 µM) caused a rapid (Fig. 4B) . The average control P o of TASK-2 currents before bupivacaine was 20.8 ± 1.6% that decreased by 73% to 5.6 ± 2.2% in the presence of 100 µM racemic bupivacaine.
Membrane depolarization. Oocytes that expressed TASK-2 had more negative resting membrane potentials than water-injected control oocytes (for TASK-2 -76.5 ± 2.2 mV and for control -49.0 ± 1 mV; p < 0.001). Bupivacaine caused an immediate and reversible depolarization of the membrane potential of oocytes expressing TASK-2 channels. Figure 5A shows tracings of membrane potentials before, during and after treatment with 300 µM R(+)-bupivacaine of TASK-2 cRNA-injected or water-injected oocytes. The bupivacaine-induced depolarization of TASK-2 cRNA-injected oocytes (15.8 ± 2.5 mV, n=6) was significantly greater than the corresponding depolarization of water-injected control oocytes (0.1 ± 0.05 mV, n=4; p < 0.001) (Fig. 5B) . The small depolarizations by 300 µM bupivacaine observed in water-injected oocytes may be explained by inhibition of endogenous background K + channels.
Chimeric TASK-1/TASK-2 channels. Oocytes injected with the chimeric cRNAs of TASK-1/TASK-2 (chimera1) and TASK-2/TASK-1 (chimera2) subunits (Fig. 6A) , 1997; Reyes et al., 1998) , showing potentiation of currents at extracellular pH>7.6 and significant inhibition at extracellular pH<7.0 (Fig. 6B) . Like their wild-type parents, both chimeric subunits were inhibited by bupivacaine in the tens of µM 
Discussion
Local anesthetics inhibit voltage-gated K+ channels (González et al., 2001b) , G proteincoupled inward rectifying K+ channels (Zhou et al., 2001 ) and the 2P K+ channels TASK-1, TASK-3, and TREK-1 (Kindler et al., 1999; Kim et al., 2000) . The present study reports potent, agent-selective local anesthetic inhibition of the 2P K+ channel TASK-2 with both whole cell and single channel recording techniques. Although TASK-2 shares only 27% and 26% amino acid sequence identity with TASK-1 and TASK-3, it belongs to the subfamily of acid-sensitive 2P K+ channels; however, its sensitivity for extracellular pH is less steep than that for TASK-1 or TASK-3. With the IC 50 s' for bupivacaine and ropivacaine in the low µM range, TASK-2 is the most sensitive 2P K+ channel to local anesthetics. The IC 50 for TASK-2 bupivacaine inhibition is in the range of the high affinity binding of the drug to the inactivated state of the cardiac Na+ channel (∼1 µM) (Clarkson and Hondeghem, 1985) . We observed a distinct local anesthetic agent specificity for TASK-2 inhibition. The ester-linked local anesthetic tetracaine, which is also highly lipid-soluble, was a much weaker inhibitor of TASK-2 currents (IC 50 >1 mM) than the amide local anesthetics bupivacaine and ropivacaine.
Chloroprocaine, another ester-linked local anesthetic, had almost no effect on TASK-2 currents. Although hydrophobic sites are important determinants of local anesthetic inhibition, the observed resistance of TASK-2 to ester-linked local anesthetics implies that structural elements contribute to the potency of inhibition. This agent-specific inhibition for TASK-2 is very similar to that previously described for the physiological flicker channel in frog myelinated axons (Bräu et al., 1995) . TASK-2 shares many electrophysiological and approximately 100 times higher than that reported for the flicker channel (0.15 µM) (Nau et al., 1999a) .
While TASK-1 lacks a stereoselective effect of local anesthetics (Kindler et al., 1999) , TASK-2 showed a stereoselective ratio (R/S) for bupivacaine and ropivacaine of ∼3.
Optically pure enantiomers of local anesthetics have now been introduced into clinical practice as less toxic alternatives to racemic mixtures (Huang et al., 1998) . The magnitude of stereoselectivity of TASK-2 inhibition by bupivacaine and ropivacaine is comparable both to the reported selectivity of inhibition of the inactivated states of voltage-gated Na+ channels (Valenzuela et al., 1995b) and to the higher systemic toxicity for R(+)-bupivacaine in animal studies (Aberg, 1972) . This stereoselective local anesthetic inhibition makes TASK-2 a potential molecular target in vivo for both the action and side effects of local anesthetics. The observed R/S ratio for TASK-2 also is similar to the recently reported stereoselective effect of the new local anesthetic IQB-9302 on the human cardiac K+ channel hKv1.5 (R/S ratio ∼3.2) (González et al., 2001a) . Higher stereoselectivity has only been reported for bupivacaine inhibition of hKv1.5 (R/S ratio ∼7) (Valenzuela et al., 1995a) and the flicker channel (R/S ratio ∼73) (Nau et al., 1999a) . Residues within the sixth transmembrane domain appear critical for stereoselective inhibition of both hKv1.5 (Franqueza et al., 1997) and Na+ channels (Nau et al., 1999b) . However, major structural differences exist between background 2P K+ channels and voltage-gated K+ and Na+ channels, preventing Local anesthetics depolarize cells expressing TASK-2 channels (Fig. 5) ; this effect could play a role in local anesthetic mechanisms. Since local anesthetics preferentially bind to the inactivated states of Na+ channels that predominate at depolarized membrane potentials (Hille et al., 1975) , inhibition of background K+ channels could increase the binding of local anesthetics to Na+ channels and enhance action potential blockade by causing partial depolarization and therefore promoting Na+ channel inactivation. Previous experimental evidence supports this hypothesis; myelinated nerves exhibiting physiological background K+ channel activity do depolarize in response to local anesthetics (Bräu et al., 1995) and background K+ channels have been shown to control the resting membrane potential of several neuronal cells (Jones, 1989) . In addition, inhibition of background K+ channels may contribute to cardiotoxic and excitotoxic side effects of local anesthetics, which cannot be entirely explained by inhibition of Na+ channels alone. Inhibition of K+ channels increases membrane excitability, which could contribute to local anesthetic-induced arrhythmias and convulsions (Zhou et al., 2001 ). This potential mechanism is supported by the finding that K+ channel openers reverse bupivacaine cardiotoxicity (de La Coussaye et al., 1993) . Local anesthetic inhibition of the acid-sensitive 2P K+ channel TASK-1 and TASK-2, both expressed in heart and CNS, occurs in the range of arterial plasma levels that are associated with local anesthetic toxicity (Kindler et al., 1999 ).
Many modulatory effects described for 2P K+ channels occur via the C-terminal domain of the respective channel; for example, activation of TASK-1 by volatile anesthetics (Talley and Bayliss, 2002) , sensitivity to arachidonic acid of TREK-2 (Kim et al., 2001) , and inhibition of TASK-1 by the transmitter thyrotropin-releasing hormone TRH (Talley and Bayliss, 2002) are dependent on an intact C-terminal tail. Our previous attempts to produce C-terminal truncation mutants of TASK-2 at amino acid positions 252 and 278 failed to produce functional ion channel activity (Gray et al., 2000) . Therefore, in the present study we constructed chimeric TASK-1/TASK-2 and TASK-2/TASK-1 2P K+ channel subunits by switching the C-terminal domains to the other 2P K+ channel. The finding that the sensitivity to bupivacaine of each chimera was influenced by the presence of the predicted intracellular C-terminal domain of TASK-2 implies that it plays a role in local anesthetic modulation. Furthermore, the permanently charged lidocaine derivative QX314 had no effect on TASK-2 currents, implying an intracellular or membrane site of action. Given that the neutral local anesthetic benzocaine was also a poor inhibitor of TASK-2, we suggest that both the ionized and unionized forms of local anesthetics participate in TASK-2 inhibitionthe uncharged species to achieve cellular penetration and the charged form to act at an intracellular or membrane site.
The activation patterns shown by the chimeric TASK channels suggest that the Cterminal tail of TASK-2 also may contribute to the delayed activation, but is not sufficient by itself. Replacing the TASK-2 C-terminal with the TASK-1 C-terminal (chimera2) significantly reduced delayed activation (fractional instantaneous current 67% for chimera2
vs. 44% for TASK-2), whereas replacing the TASK-1 C-terminal with the TASK-2 Cterminal (chimera1) had no effect on activation (fractional instantaneous current 94% for chimera1 vs. 94% for TASK-1) (Fig. 6D) . Mutational experiments of the yeast 2P K+ channel TOK1 identified regions at the cytoplasmic ends of the transmembrane segments following either of the duplicated pore loops to be important for gating of TOK1 (Loukin et al., 1997) . However, poor overall homology between TASK-2 and TOK1 (only 12% amino acid identity) and the presence of eight transmembrane segments in TOK1 compared to only four in TASK-2 make accurate alignments of the protein sequences of TASK-2 and TOK1
impossible.
In summary, we report potent, agent-specific, and stereoselective local anesthetic However, the discrepancy between these results may also be explained by differences in expression systems, such as different post-translational modifications or accessory subunits.
This article has not been copyedited and formatted. The final version may differ from this version. currents from on-cell patches at several holding potentials. The recording pipette was filled with 150 mM K-aspartate and the currents were filtered at 2 kHz. B, Single channel recordings of TASK-2 in control condition, in response to exposure to 100 µM racemic bupivacaine decreasing channel open probability from 20.8 ± 1.6% by 73% to 5.6 ± 2.2%, and following washout are shown (holding potential +40 mV). 
